Exane Derivatives’s Forterra, Inc FRTA Stock Holding History

Exane Derivatives’s Portfolio FRTA Stock Details FRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-8,421	Closed	-$198K	–	1088
2021 Q2	$198K	Buy	+8,421	New	+$197K	0.04%	393

Other funds holding FRTA

LSGA

Lone Star Global Acquisitions Hamilton, Bermuda $838M AUM 3.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

WIC

Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Exane Derivatives's FRTA Position: Q3 2021 in Review

Exane Derivatives sold out of Forterra, Inc (FRTA) in Q3 2021, closing a stake of 8,421 shares — an estimated $198K sold.

Exane Derivatives first reported a position in FRTA in Q2 2021 and held it in 1 quarter. The position peaked at $198K in Q2 2021. 118 funds tracked by Wall St. Rank hold FRTA as of Q3 2021.

Exane Derivatives reported no remaining Forterra, Inc position as of Q3 2021 after selling out during the quarter.
Exane Derivatives sold 8,421 Forterra, Inc shares in Q3 2021, an estimated $198K.
Exane Derivatives first reported a position in Forterra, Inc in Q2 2021 and held it in 1 quarter.
Exane Derivatives's Forterra, Inc position peaked at $198K in Q2 2021.
118 funds tracked by Wall St. Rank held Forterra, Inc as of Q3 2021.

Based on Exane Derivatives's 13F filing for Q3 2021, filed 26 Oct 2021.